Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00102960
Recruitment Status : Completed
First Posted : February 7, 2005
Last Update Posted : July 22, 2014
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2012
  Actual Study Completion Date : January 2013

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 17, 2017
March 7, 2017
2 February 19, 2018
March 16, 2018
3 March 19, 2018
April 17, 2018
4 May 14, 2018
June 11, 2018
Publications automatically indexed to this study by Identifier (NCT Number):